Last Updated: Jan 17, 2017
A revised policy regarding the use of the JW modifier took effect on Jan. 1, 2017. The JW modifier is used on a Medicare Part B drug claim to report the amount of drug or biological that is discarded and eligible for payment under the discarded drug policy.
Physicians and other health care providers are currently required to:
Novitas Solutions confirms that the JW modifier is not required for drugs that are not separately payable, such as packaged Outpatient Prospective Payment System drugs or drugs administered in the Federally Qualified Health Center or Rural Health Clinic setting, or drugs paid under the Part B drug Competitive Acquisition Program.
These resources offer further clarification on the JW modifier:
PAMED members with questions can call our Knowledge Center at 855-PAMED4U (855-726-3348) or email us at KnowledgeCenter@pamedsoc.org.
Thank you for the comment! Your comment must be approved first
You've already submitted a review for this item
Thank you! Your review has been submitted successfully
Login to be able to comment
Comment cannot be empty
Rating is required
You typed the code incorrectly. Please try again